Medtronic (NYSE: MDT) today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES).

Johnson & JohnsonJNJ stock jumped Wednesday after the Dow Jones health behemoth raised its 2025 guidance in the wake of a bullish second-quarter report.For the year, J&J now expects adjusted earnings ...

With EU CE mark clearance for LigaSure RAS, Medtronic expands the Hugo system’s capabilities in gynaecologic and urologic ...

Medtronic said its market-leading LigaSure technology can now be used with its Hugo soft tissue robotic surgery system in ...

Medtronic's Jason Fontana offers an update on next-generation Symplicity Spyral devices, procedures and a new feature they're ...

Japan-based Future offers specialty and workhorse guidewires. The agreement includes the first 400 cm, 0.018″ peripheral ...

Right now one of the best healthcare stocks to look at is medical device giant Medtronic ( MDT 0.39%), which is offering a ...

The company named Chad Spooner CFO of MiniMed ahead of plans to spin out the diabetes unit into a separate public firm.

Medtronic announced it has entered into an exclusive United States distribution agreement with Japan-based Future Medical Design C ...

CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward ...

Medtronic (NYSE:MDT) experienced a price increase of 7% over the last quarter, which may have been influenced by notable ...

Medtronic reported that it has begun testing an expansion of its renal denervation approach for dropping stubbornly high ...